QL
Quality of Life Outcomes (Posters)
Friday, May 29, 2015: 12:00 PM-2:00 PM
Griffin Hall
Physical Activity, Dietary Sodium, and Smoking As Correlates of Walking Performance in Persons with MS
Julia M Balto, BSc, University of Illinois at Urbana-Champaign;
Jennifer L Barnes, Ph.D., R.D., L.D.N., University of Illinois at Urbana-Champaign;
Ipek Ensari, M.Ed, University of Illinois Urbana-Champaign;
Elizabeth A Hubbard, MSc, University of Illinois at Urbana-Champaign;
Robert W Motl, PhD, University of Illinois at Urbana Champaign
Baseline Characteristics of Patients Enrolled in the Teri-PRO Phase 4 Study in the United States Vs Canada, Europe, and Latin America
Patricia K Coyle, MD, Stony Brook University Medical Center;
Christopher LaGanke, MD, North Central Neurology Associates;
Bhupendra Khatri, MD, Wheaton Franciscan Health Care St. Francis Hospital;
Ralf Gold, MD, St. Josef-Hospital, Ruhr University Bochum;
Steven Cavalier, MD, Genzyme, a Sanofi company;
Sandrine Brette, MSc, Lincoln;
Francesca Baldinetti, MD, Genzyme, a Sanofi company;
Keith R Edwards, MD, FAAN, Multiple Sclerosis Center of Northeastern New York
Hair Photography Project: Exploring the Clinical Course of Hair Thinning Associated with Teriflunomide
Keith R Edwards, MD, FAAN, Multiple Sclerosis Center of Northeastern New York;
Lori Hendin Travis, MD, Phoenix Neurological Associates Ltd;
Annette Okai, MD, Multiple Sclerosis Treatment Center of Dallas;
Scott Jackson, MD, Baton Rouge Clinic;
Lisa Farnett, PharmD, Genzyme, a Sanofi company;
Steven Cavalier, MD, Genzyme, a Sanofi company;
Darren Stam, PharmD, Genzyme, a Sanofi company;
Ken Liu, PharmD, Genzyme, a Sanofi company
Tanner Health Miles: Walking and Talking MS
Tracy Flemming Tracy, OTR/L, MSCS, MSSMC, Tanner Center for MS;
Virgina R Weinacker, DPT, Tanner Center for MS;
Emily S Riser, MD, Tanner Center for MS;
Bess Martin, PT, MSCS, Tanner Center for MS
Association Between Measures of Disability and Employment in Secondary Progressive Multiple Sclerosis: Baseline Data from the ASCEND Natalizumab Trial
Myla D Goldman, MD, Msc, University of Virginia;
Diego Cadavid, MD, Biogen Idec;
Carmen Castrillo, MD, Biogen Idec;
Yun Chen, PhD, Biogen Idec;
Qunming Dong, PhD, Biogen Idec;
Crystal Watson, MS, Biogen Idec;
Deb Steiner, MD, MS, Biogen Idec;
Daniel Mikol, MD, PhD, Biogen Idec;
Aaron E Miller, MD, Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
To What Extent Does JC Virus Status Influence Patient Decisions Regarding Treatment with Natalizumab?
William Lusher, RGN, Salford Royal NHS Trust;
Nina Jennings, BSc, RGN, Salford Royal NHS Trust;
Karen Vernon, BSc (hons). RGN., Salford Royal NHS Trust;
David Rog, MD, Salford Royal NHS Foundation Trust;
Paul Talbot, MB ChB MD FRCP, Salford Royal NHS Trust
The Impact of Relapse on Productivity, Costs, and Resource Utilization in Multiple Sclerosis: A Retrospective U.S. Database Analysis
John J Ko, PharmD, MS, The University of Texas at Austin;
Juzer Lotya, MSc. Statistics, Novartis Dublin Business Solution Centre Global Business Services;
Caitriona ONeill, MPSI, MBA, PhD, Novartis Dublin Business Solution Centre Global Business Services;
Tara A Nazareth, MPH, Novartis Pharmaceuticals Corporation;
Rahul Sasane, PhD, Novartis Pharmaceuticals Corporation
Ballroom Dance for Persons with MS: Prelimiary Efficacy
Alexander V Ng, Ph.D., Marquette University;
Sheri L Bunyan, MPT, ATC, Concordia University;
Jimin Suh, BS, Marquette University;
Tyler J Gregory, BS, Marquette University;
Shannon Gambon, BS, Marquette University;
Lauren Kalita, BS, Marquette University
A Comprehensive Revision of the Incapacity Status Scale: ISS-2
Jeffrey G. Portnoy, M.A., Ferkauf Graduate School of Psychology;
Marnina B Stimmel, B.A., Yeshiva University;
Sara Flood, M.A., Yeshiva University;
Gabriel Hoffnung, M.A., Yeshiva University;
Mary Ann Picone, M.D., Holy Name Medical Center;
Lisa Glukhovsky, M.A., Yeshiva University;
Jessica H Sloan, B.A., Yeshiva University;
Roseann Archetti, B.S., Yeshiva University;
Eliana Pasternak, M.A., Yeshiva University;
Jason Botvinick, B.A., Yeshiva University;
Elana Mendelowitz, B.A., Yeshiva University;
Frederick W Foley, Ph.D., Holy Name Medical Center
MS in US Minorities: Results of a Research Study Designed to Understand Educational Needs of Hispanic and African American Patients with MS
Gregory D Salinas, PhD, CE Outcomes, LLC;
Brandon Coleman, BS, CE Outcomes, LLC;
Eleana Hardy, BA, Biogen Idec;
Leslie Meltzer, PhD, Biogen Idec
Multiple Sclerosis (MS) Patient Adherence to Delayed-Release Dimethyl Fumarate and Patient Reported Side Effects from a Specialty Pharmacy Program
Terrie Livingston, PharmD, Biogen Idec Inc.;
Brieana Bukley, PharmD, Biogen Idec Inc.;
Francis Staskon, PhD, Walgreen, Co.;
Mark Matusik, PharmD, Walgreen, Co.;
Janeen DuChane, PhD, Walgreen, Co.
Connected CareSM for Multiple Sclerosis (MS): Improving Adherence with Managed Therapy for Patients with Indications of Fatigue or Depression
Francis Staskon, PhD, Walgreen, Co.;
Rick T Miller, RPh, Walgreen, Co.;
Janeen DuChane, PhD, Walgreen, Co.;
Mark Matusik, PharmD, Walgreen, Co.
Perceptions about MS Among Hispanic Americans: Need for Targeted Messaging
Lilyana Amezcua, MD, MS, University of Southern California;
Ana Palomeque, BS, University of Southern California;
Jose Aparicio, CCRP, University of Southern California;
Leslie Tarlow, NP, MSN, University of Southern California;
Annette M Langer-Gould, MD, PhD, Kaiser Permanente, Southern California
